Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 04, 2025

Get In Touch

Taking semaglutide turns down food noise, research suggests Diabetes and Endocrinology

Taking semaglutide turns down food noise, research suggests

  • 23 September 2025
  • 1 month ago

Half of people stop taking popular weight-loss drug within a year, national study finds Diabetes and Endocrinology

Half of people stop taking popular weight-loss drug within a year, national study finds

  • 22 September 2025
  • 1 month ago

EMA Committee approves update to Novo Nordisk Rybelsus label to reflect cardiovascular benefits Pharma News

EMA Committee approves update to Novo Nordisk Rybelsus label to reflect cardiovascular benefits

  • 18 September 2025
  • 1 month ago

Enhanced Efficacy of High-Dose Semaglutide in Obesity and Type 2 Diabetes: STEP UP Trials Find Diabetes and Endocrinology

Enhanced Efficacy of High-Dose Semaglutide in Obesity and Type 2 Diabetes: STEP UP Trials Find

  • 17 September 2025
  • 1 month ago

Higher Semaglutide Doses Safely Boost Weight Loss and Health in Adults with Obesity, Confirm Two Clinical Trials Diabetes and Endocrinology

Higher Semaglutide Doses Safely Boost Weight Loss and Health in Adults with Obesity, Confirm Two Clinical Trials

  • 16 September 2025
  • 1 month ago

Novo Nordisk Gets CDSCO Panel Nod for Rybelsus Label Update, Aligned with EMA Pharma News

Novo Nordisk Gets CDSCO Panel Nod for Rybelsus Label Update, Aligned with EMA

  • 10 September 2025
  • 1 month ago

EMA warns of sharp rise in illegal medicines sold in EU Diabetes and Endocrinology

EMA warns of sharp rise in illegal medicines sold in EU

  • 09 September 2025
  • 1 month ago

Semaglutide Tied To Meaningful Weight Loss, Waist Size Reduction And CV Benefits In Non Diabetic Overweight Adults: Study Diabetes and Endocrinology

Semaglutide Tied To Meaningful Weight Loss, Waist Size Reduction And CV Benefits In Non Diabetic Overweight Adults: Study

  • 13 July 2025
  • 3 months ago

Recent News

Nanotechnology Reverses Alzheimer's Symptoms in Mi...

  • 03 November, 2025

Gum disease could silently cause serious brain dam...

  • 03 November, 2025

Can Early-Day Fasting Significantly Boost Metaboli...

  • 03 November, 2025

Delhi HC bars doctor from running medical centre d...

  • 03 November, 2025

Phase III data for Gazyva/Gazyvaro show significan...

  • 03 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.